Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between the combination of platelet count and neutrophil-lymphocyte ratio and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study.
Kashimura S, Sato M, Inagaki T, Kin M, Manabe R, Kusumoto S, Horiike A, Tsunoda T, Kogo M. Kashimura S, et al. Among authors: manabe r. Thorac Cancer. 2024 Oct;15(28):2049-2060. doi: 10.1111/1759-7714.15437. Epub 2024 Aug 28. Thorac Cancer. 2024. PMID: 39193939 Free PMC article.
Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis.
Ando K, Akimoto K, Sato H, Manabe R, Kishino Y, Homma T, Kusumoto S, Yamaoka T, Tanaka A, Ohmori T, Sagara H. Ando K, et al. Among authors: manabe r. Cancers (Basel). 2020 Apr 10;12(4):942. doi: 10.3390/cancers12040942. Cancers (Basel). 2020. PMID: 32290309 Free PMC article. Review.
Comparative Efficacy and Safety of Lorlatinib and Alectinib for ALK-Rearrangement Positive Advanced Non-Small Cell Lung Cancer in Asian and Non-Asian Patients: A Systematic Review and Network Meta-Analysis.
Ando K, Manabe R, Kishino Y, Kusumoto S, Yamaoka T, Tanaka A, Ohmori T, Sagara H. Ando K, et al. Among authors: manabe r. Cancers (Basel). 2021 Jul 23;13(15):3704. doi: 10.3390/cancers13153704. Cancers (Basel). 2021. PMID: 34359604 Free PMC article. Review.
Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.
Ando K, Manabe R, Kishino Y, Kusumoto S, Yamaoka T, Tanaka A, Ohmori T, Ohnishi T, Sagara H. Ando K, et al. Among authors: manabe r. Curr Oncol. 2021 Feb 27;28(2):1094-1113. doi: 10.3390/curroncol28020106. Curr Oncol. 2021. PMID: 33673470 Free PMC article. Review.
219 results